Our oversight provides that structure
Taken together, GCGR agonism offers a promising yet complex strategy in cardiometabolic disease, as it promotes weight loss and energy expenditure while also increasing blood glucose, underscoring the need for dual- and triple-agonist approaches (GLP1R/GIPR/GCGR) that balance metabolic and CV effects
Key Points Semaglutide reduces appetite within the first two weeks, with most people reaching steady levels by 4-5 weeks of treatment Weight loss averages 2% by four weeks and 4% by eight weeks, with clinical studies showing a 15% average loss over 68 weeks Blood sugar improvements occur gradually, with A1C reductions of 1.2%-2.2% seen between 26-40 weeks, depending on medication type The medication works best when paired with healthy eating habits and regular physical activity for optimal results If youre taking semaglutide for weight loss or diabetes, youre probably wondering when youll start seeing results
Compatible with: Hyaluronic acid (for hydration) Niacinamide (for barrier support and tone) Growth factors Peptides (like Matrixyl or Argireline) Use with caution: Vitamin C (especially L-ascorbic acid) may destabilize copper peptides if mixed directly Retinoids can cause irritation when layered with GHK-Cu unless used at separate times (e.g., retinoid at night, GHK-Cu in the morning) AHAs and BHAs can lower skin pH and potentially reduce the effectiveness of copper peptides Spacing out these ingredients or consulting with a provider for a personalized routine can maximize benefits and avoid conflicts
What does success look like beyond weight
